Insiders Trades

★ Sign in to follow

CB

Christopher Bunka

US·SEC (Form 4)

Lexaria Bioscience Corp.

Cumul. flow

Total declarations

50

Company

1

▲ Purchases (42 ops.)

€61k

▼ Sales (0 ops.)

—

Latest filing published 12 Jan 2021 for Lexaria Bioscience Corp..

Filing timeline

BuySale

Christopher Bunka

Insider track record

Disclosed buys

42

Disclosed sells

0

Signal history

Christopher Bunka: trading record in brief

Christopher Bunka discloses dealings in Lexaria Bioscience Corp. to SEC (Form 4). Between 6 July 2016 and 11 January 2021, the trades on record add up to 50 filings.

No open-market sale appears; the market trades are 42 purchases worth €61k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants and 2 option exercises.

In size, the median ticket on the buying side is €546. Across 36 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 12 January 2021, reports a transaction in Lexaria Bioscience Corp. The latest purchase dates back some time: it was published 2,174 days ago, on 10 November 2020. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Christopher Bunka

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Lexaria Bioscience Corp. (US)

Declarations50 total

●

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives11 Jan 2021Lexaria Bioscience Corp.

0SEDI

273,543 sharesCommon SharesTSXSEDI:3661768

●

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives11 Jan 2021Lexaria Bioscience Corp.

0SEDI

215,912 sharesCommon SharesTSXSEDI:3661771

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives10 Nov 2020Lexaria Bioscience Corp.

1,950 CAD0SEDI

10,000 shares@ CA$0.195Common SharesTSXSEDI:3624976

Canonical exit: 8 Feb 2021 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives9 Nov 2020Lexaria Bioscience Corp.

1,600 CAD0SEDI

8,000 shares@ CA$0.20Common SharesTSXSEDI:3624971

Canonical exit: 7 Feb 2021 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives9 Nov 2020Lexaria Bioscience Corp.

8,063 CAD0SEDI

37,500 shares@ CA$0.215Common SharesTSXSEDI:3624968

Canonical exit: 7 Feb 2021 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives9 Nov 2020Lexaria Bioscience Corp.

4,391 CAD0SEDI

22,000 shares@ CA$0.1996Common SharesTSXSEDI:3624975

Canonical exit: 7 Feb 2021 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives9 Nov 2020Lexaria Bioscience Corp.

2,129 CAD0SEDI

10,000 shares@ CA$0.2129Common SharesTSXSEDI:3624970

Canonical exit: 7 Feb 2021 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives6 Nov 2020Lexaria Bioscience Corp.

12,306 CAD0SEDI

60,000 shares@ CA$0.2051Common SharesTSXSEDI:3624967

Canonical exit: 4 Feb 2021 (T+90)

●

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives6 May 2020Lexaria Bioscience Corp.

64,000 CAD13SEDI

200,000 shares@ CA$0.3215.9% of flowCommon SharesTSXSEDI:3547713

◆

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives3 Aug 2018Lexaria Bioscience Corp.

100,750 CAD14SEDI

81,250 shares@ CA$1.2432.6% of flowCommon SharesTSXSEDI:3219197

◇

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives18 Jun 2018Lexaria Bioscience Corp.

63,000 CAD13SEDI

450,000 shares@ CA$0.1420.0% of flowCommon SharesTSXSEDI:3199371

◇

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives18 Jun 2018Lexaria Bioscience Corp.

22,275 CAD12SEDI

247,500 shares@ CA$0.097.1% of flowCommon SharesTSXSEDI:3199369

◆

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Dec 2017Lexaria Bioscience Corp.

24,170 CAD12SEDI

29,475 shares@ CA$0.826.0% of flowCommon SharesTSXSEDI:3090240

◆

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives21 Jun 2017Lexaria Bioscience Corp.

61,950 CAD19SEDI

210,000 shares@ CA$0.295100.0% of flowCommon SharesTSXSEDI:3025011

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives7 Oct 2016Lexaria Bioscience Corp.

600 CAD17SEDI

5,000 shares@ CA$0.120.2% of flowCommon SharesTSXSEDI:2900797

Canonical exit: 5 Jan 2017 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives7 Oct 2016Lexaria Bioscience Corp.

625 CAD17SEDI

5,000 shares@ CA$0.1250.2% of flowCommon SharesTSXSEDI:2900796

Canonical exit: 5 Jan 2017 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives7 Oct 2016Lexaria Bioscience Corp.

1,290 CAD17SEDI

10,000 shares@ CA$0.1290.4% of flowCommon SharesTSXSEDI:2900795

Canonical exit: 5 Jan 2017 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives5 Oct 2016Lexaria Bioscience Corp.

363 CAD17SEDI

2,500 shares@ CA$0.1450.1% of flowCommon SharesTSXSEDI:2900086

Canonical exit: 3 Jan 2017 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives26 Aug 2016Lexaria Bioscience Corp.

653 CAD17SEDI

5,100 shares@ CA$0.1280.2% of flowCommon SharesTSXSEDI:2883243

Canonical exit: 24 Nov 2016 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives24 Aug 2016Lexaria Bioscience Corp.

375 CAD17SEDI

3,000 shares@ CA$0.1250.1% of flowCommon SharesTSXSEDI:2882391

Canonical exit: 22 Nov 2016 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives25 Aug 2016Lexaria Bioscience Corp.

655 CAD17SEDI

5,000 shares@ CA$0.1310.2% of flowCommon SharesTSXSEDI:2882393

Canonical exit: 23 Nov 2016 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives25 Aug 2016Lexaria Bioscience Corp.

1,815 CAD17SEDI

14,637 shares@ CA$0.1240.6% of flowCommon SharesTSXSEDI:2882392

Canonical exit: 23 Nov 2016 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives25 Aug 2016Lexaria Bioscience Corp.

700 CAD17SEDI

5,000 shares@ CA$0.140.2% of flowCommon SharesTSXSEDI:2882394

Canonical exit: 23 Nov 2016 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives22 Aug 2016Lexaria Bioscience Corp.

1,172 CAD17SEDI

9,300 shares@ CA$0.1260.4% of flowCommon SharesTSXSEDI:2881027

Canonical exit: 20 Nov 2016 (T+90)

▲

Christopher Bunka

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives19 Aug 2016Lexaria Bioscience Corp.

1,322 CAD17SEDI

10,500 shares@ CA$0.12590.4% of flowCommon SharesTSXSEDI:2881026

Canonical exit: 17 Nov 2016 (T+90)

25 of 50 declarations